United States Biotechnology & Medical Research

RetinalGenix Technologies Inc (RTGN)

Track

Over the last 90 days, RetinalGenix Technologies Inc. has seen one insider transaction, a proposed sale totaling $727,600. Steven Bayern, identified as a Shareholder and 10% Stockholder, has been the sole insider involved in these proposed sales, with multiple transactions occurring over the past year. The company's stock has experienced a 25.0% increase in the last 90 days.
Stock chart
Ticker: RTGN Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Steven Bayern for Bayern Capital LLC
Shareholder
1 sale — total 100,000 USD
Proposed sale 11 Jun 2026
Value US$4,640,765.06 | Price 245.88 | Shares 49,742
Proposed sale 26 Feb 2026
Value US$4,421,811.31 | Price 251.30 | Shares 5,338
Proposed sale 10 Nov 2025
Value US$247,680.00 | Price 3.20 | Shares 77,400
Proposed sale 13 Aug 2025
Value US$354,000.00 | Price 3.54 | Shares 100,000
Proposed sale 12 May 2025
Value US$352,000.00 | Price 3.52 | Shares 100,000
Proposed sale 5 Feb 2024
Value US$30,700.00 | Price 3.16 | Shares 9,700
Proposed sale 7 Nov 2023
Value US$44,900.00 | Price 4.49 | Shares 10,000
Proposed sale 31 Aug 2023
Value US$94,000.00 | Price 9.40 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-10 2026-06-11 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
49,742
245.88
US$4,640,765 		49,742 245.88 US$4,640,765
2026-02-25 2026-02-26 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
5,338
251.30
US$4,421,811 		5,338 251.30 US$4,421,811
2025-11-07 2025-11-10 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
64,227
401.43
US$4,857,377 		64,227 401.43 US$4,857,377
2025-08-12 2025-08-13 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
100,000
3.54
US$354,000 		100,000 3.54 US$354,000
2025-05-19 2025-05-12 PrS Proposed sale
Steven Bayern for Bayern Capital LLC

Shareholder
100,000
3.52
US$352,000 		100,000 3.52 US$352,000
2024-02-05 2024-02-05 PrS Proposed sale
BAYERN STEVEN

10% Stockholder

Large shareholder
9,700
3.16
US$30,700 		9,700 3.16 US$30,700
2023-11-07 2023-11-07 PrS Proposed sale
BAYERN STEVEN

10% Stockholder

Large shareholder
10,000
4.49
US$44,900 		10,000 4.49 US$44,900
2023-08-31 2023-08-31 PrS Proposed sale
BAYERN STEVEN

10% Stockholder

Large shareholder
10,000
9.40
US$94,000 		10,000 9.40 US$94,000
Explore more

More insider trading research around RetinalGenix Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America